GLP-1 drugs like Ozempic have transformed weight loss in the U.S., with nearly 12% of Americans having tried them, according to a new RAND report. Usage is especially high among women aged 50 to 64, while men catch up in older groups. Despite effectiveness, side effects like nausea and diarrhea are common, and most Americans say they don’t plan to take them.